Related references
Note: Only part of the references are listed.Characterization of quinoxaline derivatives for protection against iatrogenically induced hearing loss
Marisa Zallocchi et al.
JCI INSIGHT (2021)
Hearing loss prevalence and years lived with disability, 1990–2019: findings from the Global Burden of Disease Study 2019
Lydia M Haile et al.
LANCET (2021)
Designed, synthesized and biological evaluation of proteolysis targeting chimeras (PROTACs) as AR degraders for prostate cancer treatment
Jian-Jia Liang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Genome-wide identification of cyclin-dependent kinase (CDK) genes affecting adipocyte differentiation in cattle
Cuili Pan et al.
BMC GENOMICS (2021)
A biphenyl inhibitor of eIF4E targeting an internal binding site enables the design of cell-permeable PROTAC-degraders
Patrick D. Fischer et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Design, synthesis and biological evaluation of Proteolysis Targeting Chimeras (PROTACs) as a BTK degraders with improved pharmacokinetic properties
Saul Jaime-Figueroa et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Development of selective mono or dual PROTAC degrader probe of CDK isoforms
Fei Zhou et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Thalidomide Inhibits Human iPSC Mesendoderm Differentiation by Modulating CRBN-dependent Degradation of SALL4
David G. Belair et al.
SCIENTIFIC REPORTS (2020)
Development of CDK2 and CDK5 Dual Degrader TMX-2172
Mingxing Teng et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Optimal linker length for small molecule PROTACs that selectively target p38α and p38β for degradation
Craig Donoghue et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications
Laura Goracci et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
BRAF inhibition protects against hearing loss in mice
Matthew A. Ingersoll et al.
SCIENCE ADVANCES (2020)
Development of Dual and Selective Degraders of Cyclin-Dependent Kinases 4 and 6
Baishan Jiang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Exploring the PROTAC degron candidates: OBHSA with different side chains as novel selective estrogen receptor degraders (SERDs)
Yuanyuan Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Phenotypical microRNA screen reveals a noncanonical role of CDK2 in regulating neutrophil migration
Alan Y. Hsu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
Longchuan Bai et al.
CANCER CELL (2019)
Triazol: a privileged scaffold for proteolysis targeting chimeras
Li-Wen Xia et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel-Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7
Vittoria Zoppi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein
Haibin Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
Sajid Khan et al.
NATURE MEDICINE (2019)
PROTAC-mediated crosstalk between E3 ligases
Christian Steinebach et al.
CHEMICAL COMMUNICATIONS (2019)
Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK Inhibition
Daniel J. Wood et al.
CELL CHEMICAL BIOLOGY (2019)
A Click Chemistry Platform for the Rapid Synthesis of Bispecific Molecules for Inducing Protein Degradation
Ryan P. Wurz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor Scaffolds
Kwok-Ho Chan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals)
Matthias Schiedel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation
Calla M. Olson et al.
NATURE CHEMICAL BIOLOGY (2018)
Identification of CDK2 as a novel target in treatment of prostate cancer
Xifeng Yin et al.
FUTURE ONCOLOGY (2018)
CDK2 inhibitors as candidate therapeutics for cisplatin-and noise-induced hearing loss
Tal Teitz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss
Robert A. Hazlitt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Plasticity in binding confers selectivity in ligand-induced protein degradation
Radoslaw P. Nowak et al.
NATURE CHEMICAL BIOLOGY (2018)
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands
Lara N. Gechijian et al.
NATURE CHEMICAL BIOLOGY (2018)
Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss
P. R. Brock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Delineating the role of cooperativity in the design of potent PROTACs for BTK
Adelajda Zorba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Development of Second-Generation CDK2 Inhibitors for the Prevention of Cisplatin-Induced Hearing Loss
Robert A. Hazlitt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy (ACCL05C1): A Report From the Children's Oncology Group
Kristin R. Knight et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial
David R. Freyer et al.
LANCET ONCOLOGY (2017)
Structural basis of PROTAC cooperative recognition for selective protein degradation
Morgan S. Gadd et al.
NATURE CHEMICAL BIOLOGY (2017)
Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection
Sandeep Sheth et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation
Chiara Maniaci et al.
NATURE COMMUNICATIONS (2017)
Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer
Angela Alexander et al.
ONCOTARGET (2017)
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)
Caroline M. Robb et al.
CHEMICAL COMMUNICATIONS (2017)
Recognition of substrate degrons by E3 ubiquitin ligases and modulation by small-molecule mimicry strategies
Xavier Lucas et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2017)
Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands
David Remillard et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL
Ashton C. Lai et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Small-Molecule PROTACS: New Approaches to Protein Degradation
Momar Toure et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Drugging the undruggables: exploring the ubiquitin system for drug development
Xiaodong Huang et al.
CELL RESEARCH (2016)
Cyclin-Dependent Kinase 2 Promotes Tumor Proliferation and Induces Radio Resistance in Glioblastoma
Jia Wang et al.
TRANSLATIONAL ONCOLOGY (2016)
Protein Degradation by In-Cell Self-Assembly of Proteolysis Targeting Chimeras
Honorine Lebraud et al.
ACS CENTRAL SCIENCE (2016)
Targeting Cullin-RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation
Emil Bulatov et al.
BIOCHEMICAL JOURNAL (2015)
Recent advances in local drug delivery to the inner ear
Naila El Kechai et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
James A. Maier et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
New Ways to Boost Molecular Dynamics Simulations
Elmar Krieger et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2015)
Catalytic in vivo protein knockdown by small-molecule PROTACs
Daniel P. Bondeson et al.
NATURE CHEMICAL BIOLOGY (2015)
New treatment options for hearing loss
Ulrich Mueller et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Phthalimide conjugation as a strategy for in vivo target protein degradation
Georg E. Winter et al.
SCIENCE (2015)
Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression
Liu Yang et al.
ONCOTARGET (2015)
HOXA7 stimulates human hepatocellular carcinoma proliferation through cyclin E1/CDK2
Yuehui Li et al.
ONCOLOGY REPORTS (2015)
Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours
D. S. Boss et al.
ANNALS OF ONCOLOGY (2010)
Jostling for Position: Optimizing Linker Location in the Design of Estrogen Receptor-Targeting PROTACs
Kedra Cyrus et al.
CHEMMEDCHEM (2010)
Cyclin-dependent kinases: a family portrait
Marcos Malumbres et al.
NATURE CELL BIOLOGY (2009)
Inhibition of cyclin-dependent kinase-2 induces apoptosis in human diffuse large B-cell lymphomas
Anthony C. Faber et al.
CELL CYCLE (2007)
A phase I pharmacodynamic study of the effects of the cyclin-dependent kinase-inhibitor AZD5438 on cell cycle markers within the buccal mucosa, plucked scalp hairs and peripheral blood mononucleocytes of healthy male volunteers
D. Ross Camidge et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
A first-in-man phase I tolerability and pharmacokinetic study of the cyclin-dependent kinase-inhibitor AZD5438 in healthy male volunteers
D. Ross Camidge et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
KM Sakamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
